Kestra Advisory Services’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,818	Closed	-$35.9K	–	2633
2024 Q3	$35.9K	Buy	13,818 +3,000	+28%	+$7.8K	﹤0.01%	2503
2024 Q2	$32K	Buy	+10,818	New	+$32K	﹤0.01%	2567